[AKRO] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
10-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -33.03%
YoY- -13.43%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 284 0 0 0 0 0 -
PBT -53,344 -55,186 -39,659 -31,083 -25,831 -23,059 -35,542 31.05%
Tax -42 -12,527 8,732 6,260 -2,465 -2,574 -549 -81.95%
NP -53,344 -55,186 -39,659 -31,083 -23,366 -20,485 -34,993 32.42%
Tax Rate - - - - - - - -
Total Cost 53,344 55,470 39,659 31,083 23,366 20,485 34,993 32.42%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 -19,431.69 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.90 -0.99 -0.71 -0.60 -0.50 -0.44 -0.91 -0.73%
EPS Diluted -0.90 -0.99 -0.71 -0.60 -0.50 -0.44 -0.91 -0.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.